Indapamide Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Spironolactone Versus Indapamide in Obese and Hypertensive Patients
Condition:   Hypertension Interventions:   Drug: amlodipine+spironolactone;   Drug: amlodipine+indapamide Sponsors:   Peking University Third Hospital;   University of Michigan;   Peking University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 13, 2018 Category: Research Source Type: clinical trials

Spironolactone Versus Indapamide in Obese and Hypertensive Patients
Condition:   Hypertension Interventions:   Drug: Spironolactone;   Drug: Indapamide;   Drug: Amlodipine Sponsors:   Peking University Third Hospital;   University of Michigan;   Peking University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 13, 2018 Category: Research Source Type: clinical trials

Spironolactone Versus Indapamide in Obese and Hypertensive Patients
Condition:   Hypertension Interventions:   Drug: amlodipine+spironolactone;   Drug: amlodipine+indapamide Sponsors:   Peking University Third Hospital;   University of Michigan;   Peking University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 13, 2018 Category: Research Source Type: clinical trials

Fimasartan in the Senior Subjects
Condition:   The Elderly (≥ 70 Years) With Essential Hypertension Interventions:   Drug: Fimasartan or Fimasartan/Hydrochlorothiazide;   Drug: Perindopril or Perindopril/Indapamide Sponsor:   Boryung Pharmaceutical Co., Ltd Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2017 Category: Research Source Type: clinical trials